Overview

Observational Study to Observe the Safety of LevemirĀ® Treatment in Children and Adolescents With Type 1 Diabetes

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This observational study is conducted in Europe. The trial aims to observe the incidence of serious adverse drug reactions in children and adolescents with type 1 diabetes during LevemirĀ® treatment.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir